A 38-year-old woman with a family history of episodic paralysis presents with acute onset flaccid weakness of the lower limbs lasting 4 hours, followed by complete recovery. Serum potassium during the episode was 2.1 mEq/L (normal 3.5–5.0). Which investigation would be most appropriate to confirm the diagnosis and assess the underlying ion channel dysfunction affecting the resting membrane potential?

Explanation

## Investigation of Choice: Genetic Testing for Ion Channel Mutations **Key Point:** Hypokalemic periodic paralysis is caused by mutations in genes encoding voltage-gated calcium (CACNA1S) or sodium (SCN4A) channels. Genetic testing is the definitive diagnostic investigation for confirming the underlying molecular defect affecting the resting membrane potential. ### Clinical Context: Hypokalemic Periodic Paralysis **High-Yield:** The clinical presentation — episodic flaccid paralysis with hypokalemia (K⁺ = 2.1 mEq/L) — is pathognomonic for hypokalemic periodic paralysis: - **CACNA1S mutations** (60–70% of cases) — affect L-type calcium channels in skeletal muscle - **SCN4A mutations** (15–20% of cases) — affect voltage-gated sodium channels ### Mechanism: Ion Channel Dysfunction and Resting Membrane Potential **Key Point:** The resting membrane potential is determined by the **Nernst equation** and **Goldman-Hodgkin-Katz equation**: $$V_m = 61 \log \frac{[K^+]_{out}}{[K^+]_{in}}$$ In hypokalemic periodic paralysis: 1. **Abnormal ion channel function** → impaired K⁺ efflux during exercise or carbohydrate loading 2. **Acute hypokalemia** → hyperpolarization of the resting membrane potential (becomes more negative) 3. **Reduced excitability** → muscle cannot generate action potentials → flaccid paralysis 4. **Spontaneous recovery** → K⁺ redistributes back to extracellular space → resting membrane potential normalizes **Clinical Pearl:** The hypokalemia is due to **intracellular K⁺ shift** (not total body K⁺ depletion), which is why serum K⁺ normalizes spontaneously even without treatment. ### Why Genetic Testing Is Superior | Investigation | Confirms Diagnosis? | Identifies Cause? | Assesses Ion Channel Defect? | Timing Dependency? | | --- | --- | --- | --- | --- | | **Genetic testing (CACNA1S/SCN4A)** | Yes (definitive) | Yes (specific mutation) | Yes (direct) | No — can be done anytime | | EMG during episode | No | No | No | Yes — must be during paralysis | | Serum K⁺ at rest | No | No | No | Yes — only abnormal during episode | | RNS test | No | No | No | No — typically normal in periodic paralysis | **Mnemonic: CACNA1S = **C**alcium **A**lpha **C**hannel **N**euromusculAr **A**bnormality — **S**keletal muscle ### Why Genetic Testing Is Definitive **Key Point:** Genetic testing: - Identifies the specific ion channel mutation causing the defect - Confirms the diagnosis even when serum K⁺ is normal (between episodes) - Enables genetic counseling and family screening - Guides treatment (e.g., acetazolamide for CACNA1S; avoid in SCN4A) - Is not time-dependent (unlike EMG or serum K⁺ measurement) [cite:Harrison's Principles of Internal Medicine 21e Ch 382]